BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26165090)

  • 41. Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients.
    Danielsson O; Lindvall B; Gati I; Ernerudh J
    J Rheumatol; 2013 Jul; 40(7):1173-82. PubMed ID: 23637317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoantibodies in inflammatory myopathies.
    Garlepp MJ; Mastaglia FL
    Am J Med Sci; 2000 Apr; 319(4):227-33. PubMed ID: 10768607
    [No Abstract]   [Full Text] [Related]  

  • 43. Review of the classification and assessment of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):2. PubMed ID: 19336019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory myopathies.
    Leong KH; Boey ML
    Singapore Med J; 1992 Apr; 33(2):186-8. PubMed ID: 1621126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Myositis: From classification to diagnosis].
    Fer F; Allenbach Y; Benveniste O
    Rev Med Interne; 2021 Jun; 42(6):392-400. PubMed ID: 33248855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
    Dugan EM; Huber AM; Miller FW; Rider LG;
    Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
    Bertorini TE
    Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of new biomarkers of idiopathic inflammatory myopathy.
    Lu X; Peng Q; Wang G
    Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
    Dalakas MC
    Acta Myol; 2020 Dec; 39(4):289-301. PubMed ID: 33458584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Evaluation and Management of Inflammatory Myopathies.
    Chhibber S; Amato AA
    Semin Neurol; 2015 Aug; 35(4):347-59. PubMed ID: 26502759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.
    Neri R; Barsotti S; Iacopetti V; Iacopetti G; Pepe P; d'Ascanio A; Tavoni AG; Mosca M; Bombardieri S
    Rheumatol Int; 2014 Apr; 34(4):565-9. PubMed ID: 24322453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification criteria for the idiopathic inflammatory myopathies.
    Targoff IN; Miller FW; Medsger TA; Oddis CV
    Curr Opin Rheumatol; 1997 Nov; 9(6):527-35. PubMed ID: 9375282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Inflammatory myopathies].
    Schoser B
    Z Rheumatol; 2009 Oct; 68(8):665-75; quiz 676-7. PubMed ID: 19756663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.
    Betteridge Z; McHugh N
    J Intern Med; 2016 Jul; 280(1):8-23. PubMed ID: 26602539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease.
    Sordet C; Goetz J; Sibilia J
    Joint Bone Spine; 2006 Dec; 73(6):646-54. PubMed ID: 17110150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical spectrum of inflammatory myositis in South India--a ten year study.
    Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P
    J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory myopathies: Part 1.
    Mastaglia FL; Ojeda VJ
    Ann Neurol; 1985 Mar; 17(3):215-27. PubMed ID: 2986525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.